Universe Pharmaceuticals INC Proceeds from Debt, Net of Issuance Costs
Universe Pharmaceuticals INC (UPC) had Proceeds from Debt, Net of Issuance Costs of $24.63 million as of 2024-07-15, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-01-29
- 2024-07-15: Proceeds from Debt, Net of Issuance Costs $24.63M.
- 2021-03-29: Proceeds from Debt, Net of Issuance Costs $25.60M.
- 2021-03-25: Proceeds from Debt, Net of Issuance Costs $28.75M.
| Period end | Proceeds from Debt, Net of Issuance Costs |
|---|---|
| 2024-07-15 | $24.63M 20-F · filed 2026-01-29 |
| 2021-03-29 | $25.60M 6-K · filed 2023-08-31 |
| 2021-03-25 | $28.75M 20-F · filed 2023-02-10 |